Drugs / vetaporfin
last change May 2008 re-read 3 minutes ago

vetaporfin

Developed for
age-related macular degeneration

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT00684853 Comparator Nov 2007 → May 2008 age-related macular degeneration Federal University of São Paulo Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as vetaporfin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00684853 ↗